Low-Density Lipoprotein (Ldl) Cholesterol Sub-Fraction Test
The Low-Density Lipoprotein (LDL) Cholesterol Sub-Fraction Test is an in vitro diagnostic device intended for the quantitative determination of low-density lipoprotein cholesterol sub-fractions in human specimens, used in the assessment of cardiovascular risk. It is classified as a Class 1 device under regulation 862.1475, subject to general controls and eligible for third-party 510(k) review. The product code is PYP, and it falls within the Clinical Chemistry (CH) medical specialty. It is not an implant and is not life-sustaining.
Basic Information
- Product Code
- PYP
- Device Class
- FDA class 1
- Regulation Number
- 862.1475
- Medical Specialty
- Clinical Chemistry
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
Definition
For the quantitative determination of low-density lipoprotein (LDL) cholesterol sub-fractions.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K161679 | s LDL-EX SEIKEN | Aug 18, 2017 | Substantially Equivalent | Denka Seiken Co., Ltd. |
FEI Numbers
This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.